🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/07/1997 | 48,66 | 50,06 | 48,66 | 49,36 | -0,47% | 2,88% | 13.919 |
| 03/07/1997 | 48,66 | 50,30 | 48,66 | 49,59 | +1,92% | 3,37% | 24.125 |
| 02/07/1997 | 47,49 | 50,53 | 47,49 | 48,66 | +2,46% | 6,40% | 46.594 |
| 01/07/1997 | 48,19 | 48,19 | 47,26 | 47,49 | -1,46% | 1,94% | 21.026 |
| 30/06/1997 | 47,96 | 48,19 | 45,85 | 48,19 | +0,98% | 4,88% | 65.215 |
| 27/06/1997 | 46,32 | 47,96 | 46,32 | 47,72 | +1,49% | 3,54% | 22.682 |
| 26/06/1997 | 47,26 | 47,72 | 44,68 | 47,02 | +0,00% | 6,44% | 72.723 |
| 25/06/1997 | 48,66 | 49,36 | 46,79 | 47,02 | -5,19% | 5,29% | 30.778 |
| 24/06/1997 | 51,00 | 51,00 | 48,19 | 49,59 | -2,75% | 5,50% | 41.277 |
| 23/06/1997 | 52,17 | 52,17 | 50,53 | 51,00 | -0,91% | 3,14% | 14.053 |
| 20/06/1997 | 51,93 | 52,40 | 51,47 | 51,47 | -1,79% | 1,80% | 19.904 |
| 19/06/1997 | 51,93 | 52,87 | 51,93 | 52,40 | +0,00% | 1,80% | 32.888 |
| 18/06/1997 | 51,47 | 54,27 | 51,47 | 52,40 | +1,82% | 5,45% | 80.684 |
| 17/06/1997 | 51,00 | 51,47 | 51,00 | 51,47 | +0,46% | 0,92% | 20.919 |
| 16/06/1997 | 51,23 | 51,70 | 51,00 | 51,23 | +0,00% | 1,37% | 85.814 |
| 13/06/1997 | 51,70 | 51,93 | 51,23 | 51,23 | -0,90% | 1,36% | 51.723 |
| 12/06/1997 | 51,23 | 51,70 | 51,23 | 51,70 | +0,91% | 0,91% | 50.414 |
| 11/06/1997 | 51,70 | 51,70 | 51,00 | 51,23 | +0,00% | 1,36% | 26.850 |
| 10/06/1997 | 51,00 | 52,17 | 50,06 | 51,23 | +1,86% | 4,13% | 63.212 |
| 09/06/1997 | 50,76 | 51,00 | 50,06 | 50,30 | +0,00% | 1,84% | 41.491 |
| 06/06/1997 | 49,59 | 51,93 | 49,59 | 50,30 | +0,47% | 4,72% | 155.838 |
| 05/06/1997 | 48,66 | 50,06 | 47,72 | 50,06 | +2,88% | 4,81% | 69.089 |
| 04/06/1997 | 47,72 | 48,66 | 46,79 | 48,66 | +4,00% | 3,92% | 22.896 |
| 03/06/1997 | 47,72 | 48,66 | 46,79 | 46,79 | -2,44% | 3,92% | 33.690 |
| 02/06/1997 | 43,51 | 48,66 | 43,04 | 47,96 | +7,89% | 12,90% | 85.413 |
| 30/05/1997 | 44,45 | 44,92 | 43,10 | 44,45 | +0,00% | 4,08% | 54.422 |
| 29/05/1997 | 44,92 | 44,92 | 44,45 | 44,45 | -1,04% | 1,04% | 30.003 |
| 28/05/1997 | 44,45 | 45,38 | 44,45 | 44,92 | -0,52% | 2,11% | 37.403 |
| 27/05/1997 | 44,92 | 45,38 | 44,45 | 45,15 | +0,52% | 2,08% | 43.949 |
| 23/05/1997 | 44,45 | 44,92 | 43,51 | 44,92 | +2,13% | 3,16% | 16.083 |